Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (431-440 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|December 9, 2014
Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometryLei Zhu, Qingcheng Guo, Huaizu Guo, et al.
Mabs|December 9, 2014
Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopesChristine J Rossant, Danielle Carroll, Ling Huang, et al.
Mabs|December 9, 2014
Monitoring therapeutic monoclonal antibodies in brain tumorRima Ait-Belkacem, Caroline Berenguer, Claude Villard, et al.
Mabs|December 9, 2014
An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivoFeifan Yu, Lindvi Gudmundsdotter, Anastassja Akal, et al.
Mabs|December 20, 2014
Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibodyHarald Rouha, Adriana Badarau, Zehra C Visram, et al.
Mabs|December 20, 2014
Therapeutic monoclonal antibodies and the need for targeted pharmacovigilance in IndiaM Kalaivani, Abhishank Singh, V Kalaiselvan
Mabs|December 20, 2014
Structural insights and biomedical potential of IgNAR scaffolds from sharksStefan Zielonka, Martin Empting, Julius Grzeschik, et al.
Mabs|December 23, 2014
The therapeutic monoclonal antibody marketDawn M Ecker, Susan Dana Jones, Howard L Levine
Mabs|June 11, 2016
The use of CrossMAb technology for the generation of bi- and multispecific antibodiesChristian Klein, Wolfgang Schaefer, Jörg T Regula
Mabs|November 23, 2013
Drugs derived from phage display: from candidate identification to clinical practiceAndrew E Nixon, Daniel J Sexton, Robert C Ladner
Pageof 184

Showing results (431-440 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|December 9, 2014
Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometryLei Zhu, Qingcheng Guo, Huaizu Guo, et al.
Mabs|December 9, 2014
Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopesChristine J Rossant, Danielle Carroll, Ling Huang, et al.
Mabs|December 9, 2014
Monitoring therapeutic monoclonal antibodies in brain tumorRima Ait-Belkacem, Caroline Berenguer, Claude Villard, et al.
Mabs|December 9, 2014
An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivoFeifan Yu, Lindvi Gudmundsdotter, Anastassja Akal, et al.
Mabs|December 20, 2014
Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibodyHarald Rouha, Adriana Badarau, Zehra C Visram, et al.
Mabs|December 20, 2014
Therapeutic monoclonal antibodies and the need for targeted pharmacovigilance in IndiaM Kalaivani, Abhishank Singh, V Kalaiselvan
Mabs|December 20, 2014
Structural insights and biomedical potential of IgNAR scaffolds from sharksStefan Zielonka, Martin Empting, Julius Grzeschik, et al.
Mabs|December 23, 2014
The therapeutic monoclonal antibody marketDawn M Ecker, Susan Dana Jones, Howard L Levine
Mabs|June 11, 2016
The use of CrossMAb technology for the generation of bi- and multispecific antibodiesChristian Klein, Wolfgang Schaefer, Jörg T Regula
Mabs|November 23, 2013
Drugs derived from phage display: from candidate identification to clinical practiceAndrew E Nixon, Daniel J Sexton, Robert C Ladner
Pageof 184